← SynDRA
MALOTILATE
SynDRA canonical compound SYN0026529 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | protein synthesis stimulant |
|---|
| Indication | hepatic cirrhosis |
|---|
| Disease area | gastroenterology |
|---|
Mechanisms of action (all sources)
- protein synthesis stimulant
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PDE4D
- NR1I2
- ADORA1
- OPRD1
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR3C1
- OPRK1
- HRH3
- OPRM1
- PDE3A
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- TDP1
- HTR1A
- HRH2
- ADORA2A
- CCKAR
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2CJ
- CP3A7
- GLI3
- GPR32
- PRGR
Cross-references
Synonyms
- kantec
- Malotilato
- Hepation
- Kantec
- NKK-105
- Malotilatum
- Diisopropyl-1,3-dithiol-2-ylidenemalonate
- RV59PND975
- DTXCID5026463
- RefChem:925240
- dipropan-2-yl 2-(1,3-dithiol-2-ylidene)propanedioate
- MFCD00867646
- Diisopropyl 2-(1,3-dithiol-2-ylidene)malonate
- NCGC00164588-01
- Malotilatum [INN-Latin]
- Malotilato [INN-Spanish]
- Malotilate [USAN:INN:JAN]
- CAS-59937-28-9
- EINECS 261-987-3
- CL-1500
- UNII-RV59PND975
- Tractal
- Kantec (TN)
- Diisopropyl 1,3-dithiole-delta(sup 2,alpha)-malonate
- MALOTILATE [MI]
- MALOTILATE [INN]
- MALOTILATE [JAN]
- MALOTILATE [USAN]
- MALOTILATE [MART.]
- MALOTILATE [WHO-DD]
- MLS006010037
- Malotilate (JAN/USAN/INN)
- SCHEMBL635496
- diisopropyl 2-(1,3-dithiol-2-ylidene)propanedioate
- Malotilate - Bio-X trade mark
- orb1300644
- CHEBI:31798
- GLXC-04578
Look up MALOTILATE in the interactive SynDRA portal →